FDA.reportPublic FDA data

Reyvow

Manufacturer
Eli Lilly and Company
Effective date
2025-01-08
Label type
HUMAN PRESCRIPTION DRUG LABEL
Version
3
Source
legacy-cache
Hydrated at
2026-08-01 20:43:10

Label at a glance#

ProductReyvow
Active ingredientlasmiditan
Label structure2 sections

Label contents#

Full prescribing information#

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

PACKAGE LABEL - REYVOW 50 mg 4ct carton - FOR EXPORT ONLY

Packaging Image for NDC 0002-0265-04

4 tablets (1 card of 4 tablets)

REYVOW™

(lasmiditan)

tablets 50 mg

For oral use.

Each tablet contains 50 mg of lasmiditan.

Rx only

50 mg

Dispense enclosed Medication Guide to each patient.

Lilly

PDP Text – REYVOW 50 mg 8ct carton - FOR EXPORT ONLY
PDP Text – REYVOW 50 mg 8ct carton - FOR EXPORT ONLY

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

PACKAGE LABEL - REYVOW 100 mg 4ct carton - FOR EXPORT ONLY

Packaging Image for NDC 0002-0632-04

4 tablets (1 card of 4 tablets)

REYVOW™

(lasmiditan)

tablets 100 mg

For oral use.

Each tablet contains 100 mg of lasmiditan.

Rx only

100 mg

Dispense enclosed Medication Guide to each patient.

Lilly

PDP Text – REYVOW 100 mg carton - FOR EXPORT ONLY
PDP Text – REYVOW 100 mg carton - FOR EXPORT ONLY

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
0002-0265REYVOW (LASMIDITAN) TABLET [ELI LILLY AND COMPANY]3Unmatched20250110_4da4eece-c3eb-4b2a-ae9e-7d040b29a334.zip
0002-0632REYVOW (LASMIDITAN) TABLET [ELI LILLY AND COMPANY]3Unmatched20250110_4da4eece-c3eb-4b2a-ae9e-7d040b29a334.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 13 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
0002-02650002-0265-04
0002-06320002-0632-04

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 23 matching rows.

Name, UNII, Kind table
NameUNIIKind
lasmiditan760I9WM792ACTIB
Microcrystalline celluloseOP1R32D61UIACT
Starch, cornO8232NY3SJIACT
Croscarmellose SodiumM28OL1HH48IACT
Sodium Lauryl Sulfate368GB5141JIACT
Magnesium Stearate70097M6I30IACT
Polyvinyl Alcohol, Unspecified532B59J990IACT
Titanium dioxide15FIX9V2JPIACT
Polyethylene Glycol 3350G2M7P15E5PIACT
Talc7SEV7J4R1UIACT
Ferrosoferric OxideXM0M87F357IACT
lasmiditan760I9WM792ACTIB
Microcrystalline celluloseOP1R32D61UIACT
Starch, cornO8232NY3SJIACT
Croscarmellose SodiumM28OL1HH48IACT
Sodium Lauryl Sulfate368GB5141JIACT
Magnesium Stearate70097M6I30IACT
Polyvinyl Alcohol, Unspecified532B59J990IACT
Titanium dioxide15FIX9V2JPIACT
Polyethylene Glycol 3350G2M7P15E5PIACT
Talc7SEV7J4R1UIACT
Ferrosoferric OxideXM0M87F357IACT
Ferric Oxide Red1K09F3G675IACT

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
df034d03-07f9-4ae2-aa5c-2fc600c89eb24da4eece-c3eb-4b2a-ae9e-7d040b29a3342026-01-08Exact identifier
spl set id: 4da4eece-c3eb-4b2a-ae9e-7d040b29a334

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.